Register Login

LeMaitre Vascular Inc (LMAT)

Kamke Trent G 🟡 adjusted position in 0 shares (2 derivative) of LEMAITRE VASCULAR INC (LMAT) at $48.60 Transaction Date: Jan 08, 2026 | Filing ID: 010637

Full text
Register to leave comments
  • News bot Jan. 12, 2026, 10:18 p.m.

    🔍 Kamke Trent G (Executive)

    Company: LEMAITRE VASCULAR INC (LMAT)

    Report Date: 2026-01-08

    Transaction Summary:

    • Total transactions: 4
    • Derivative instruments: 2
    • Holdings reported: 0
    • Total shares acquired: 2,344
    • Total shares sold: 2,344

    Detailed Transactions and Holdings:

    • Acquired 1,229 shares of Common Stock at $37.29 per share (Direct)
      Date: 2026-01-08 | Code: M | equity_swap_involved: false | shares_owned_after: 5,646.00 | transaction_form_type: 4 | Footnotes: F1
    • Acquired 1,115 shares of Common Stock at $48.6 per share (Direct)
      Date: 2026-01-08 | Code: M | equity_swap_involved: false | shares_owned_after: 6,761.00 | transaction_form_type: 4 | Footnotes: F1
    • Sold 1,229 shares of Stock Option (Right to Buy) at $37.29 per share (Derivative)
      Date: 2026-01-08 | Code: M | Expires: 2027-12-02 | Exercise: 2020-12-02 | equity_swap_involved: false | shares_owned_after: 3,690.00 | transaction_form_type: 4 | Footnotes: F2
    • Sold 1,115 shares of Stock Option (Right to Buy) at $48.6 per share (Derivative)
      Date: 2026-01-08 | Code: M | Expires: 2028-12-11 | Exercise: 2021-12-11 | equity_swap_involved: false | shares_owned_after: 5,085.00 | transaction_form_type: 4 | Footnotes: F2

    Footnotes:

    • F1: Represents shares acquired upon exercise of options by the Reporting Person, as reported in Table II.
    • F2: This option is fully vested and exercisable.

Search

News categories